Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK)
HKSE · HKD · Healthcare · Medical Devices
HK$19.26 (-0.57%) as of
Key statistics
- Market cap
- 6.35B
- P/E (TTM)
- 18.00
- Forward P/E
- 11.23
- EPS (TTM)
- 1.070
- Dividend yield
- 1.30%
- 52-week range
- 17.100 – 28.000
- Beta
- 0.33
- Revenue (TTM)
- 1.21B
- Profit margin
- 25.25%
- Analyst target
- HK$31.20
- Volume
- 292.05k
About Zylox-Tonbridge Medical Technology Co., Ltd.
Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People's Republic of China and internationally. It offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. The company's peripheral-vascular interventional product portfolio includes stents, balloons, catheters, and filters, as well as covers hemodialysis access, arterial, venous, peripheral embolization intervention, and other intervention products. In addition, the company provides technical consultation and services, as well as imports materials. It serves patients and physicians. The company was formerly known as Zhejiang Zylox Medical Device Co., Ltd. and changed its name to Zylox-Tonbridge Medical Technology Co., Ltd. in March 2021. Zylox-Tonbridge Medical Technology Co., Ltd. was incorporated in 2012 and is headquartered in Hangzhou, the People's Republic of China.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Hangzhou, China
- Employees
- 1,214
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.